NovoNordisk’s Once-Weekly Insulin Controls Blood Sugar as Well as Daily Injections

NovoNordisk has reported that its once-a-week form of insulin controlled blood sugar as well as short-acting insulin with a similar rate of hypoglycemic events in a late-stage trial.
Source: Drug Industry Daily